Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117524035 | 11752403 | 5 | F | 20151018 | 20160629 | 20151118 | 20160706 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-64381NB | BOEHRINGER INGELHEIM | 69.96 | YR | F | Y | 44.00000 | KG | 20160706 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117524035 | 11752403 | 1 | PS | GILOTRIF | AFATINIB | 1 | Oral | 40 MG | 201292 | 40 | MG | FILM COATED TABLET | QD | ||||||
117524035 | 11752403 | 2 | SS | LOPERAMIDE | LOPERAMIDE | 1 | Oral | 2 MG | 0 | 2 | MG | QD | |||||||
117524035 | 11752403 | 3 | C | DENOTAS | CALCIUM CARBONATECHOLECALCIFEROLMAGNESIUM CARBONATE | 1 | Oral | 2 ANZ | 0 | TABLET | QD | ||||||||
117524035 | 11752403 | 4 | C | RANMARK | DENOSUMAB | 1 | Subcutaneous | 120 MG | 0 | 120 | MG | INJECTION | QD | ||||||
117524035 | 11752403 | 5 | C | BROTIZOLAM | BROTIZOLAM | 1 | Oral | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117524035 | 11752403 | 1 | Lung adenocarcinoma |
117524035 | 11752403 | 2 | Prophylaxis against diarrhoea |
117524035 | 11752403 | 3 | Prophylaxis |
117524035 | 11752403 | 4 | Metastases to bone |
117524035 | 11752403 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117524035 | 11752403 | LT |
117524035 | 11752403 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117524035 | 11752403 | Decreased appetite | |
117524035 | 11752403 | Diarrhoea | |
117524035 | 11752403 | Rash | |
117524035 | 11752403 | Toxic epidermal necrolysis | |
117524035 | 11752403 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117524035 | 11752403 | 1 | 20151017 | 20151109 | 0 | |
117524035 | 11752403 | 2 | 20151012 | 0 | ||
117524035 | 11752403 | 3 | 20140729 | 0 | ||
117524035 | 11752403 | 4 | 20140729 | 0 |